Bank of New York Mellon’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.37M | Buy |
|
|||||
|
2025
Q2 | $1.97M | Buy |
|
|||||
|
2025
Q1 | $1.84M | Buy |
|
|||||
|
2024
Q4 | $2.02M | Sell |
|
|||||
|
2024
Q3 | $2.31M | Sell |
|
|||||
|
2024
Q2 | $2.67M | Buy |
|
|||||
|
2024
Q1 | $1.35M | Sell |
|
|||||
|
2023
Q4 | $1.11M | Sell |
|
|||||
|
2023
Q3 | $1.1M | Sell |
|
|||||
|
2023
Q2 | $1.65M | Buy |
|
|||||
|
2023
Q1 | $335K | Buy |
|
|||||
|
2022
Q4 | $213K | Sell |
|
|||||
|
2022
Q3 | $120K | Hold |
|
|||||
|
2022
Q2 | $64K | Sell |
|
|||||
|
2022
Q1 | $131K | Buy |
|
|||||
|
2021
Q4 | $42K | Hold |
|
|||||
|
2021
Q3 | $76K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $153K | Sell |
|
|||||
|
2020
Q4 | $580K | Buy |
|
|||||
|
2020
Q3 | $293K | Sell |
|
|||||
|
2020
Q2 | $421K | Buy |
|